FM

Ferran Marti

Healthtech & Life Sciences | Private Equity & Venture Capital

Greater Barcelona Metropolitan Area

Invests in

Stages:

Locations:

  • Min Investment:

    $10,000,000.00
  • Max Investment:

    $50,000,000.00
  • Target Investment:

    $25,000,000.00

Work Experience

  • Corporate Strategy & Finance Manager

    2025

    ● Corporate Strategy: Collaborating with the Chief Strategy Officer on global strategic initiatives across markets and business units. ● Investor Relations: Supporting the CFO in preparing materials for current and prospective investors, including monthly reports, board presentations, and due diligence documentation. ● Strategic Finance: Leading global revenue projections, budgeting processes, and cost optimization initiatives for tech and product teams.

2024 - 2024

  • Consultant

    2024 - 2024

    ● Project Management: Led healthcare and life science projects across Europe and the US for corporates and private equity firms. ● Financial Modeling: Built extensive financial models using advanced Excel modeling techniques. ● Presentation Skills: Created and delivered strategic presentations to clients, translating research into actionable insights.

2020 - 2024

  • Board Member

    2020 - 2024

    Served as Board Member for several portfolio companies at Nina Capital, including: ● Healee: Patient access solutions for healthcare organizations; the largest healthcare provider aggregator in Bulgaria. ● Taika3D: Automatic generation of 3D orthotic designs using artificial intelligence. ● IMA Health: Digital medication management platform to support patients with chronic diseases. ● Sarcura: Developing chip-based cell manufacturing technologies to enable scalable and precise cell therapy production. ● BioLib: Bioinformatics pipelines enabling state-of-the-art protein design for biopharma. ● Zetta Genomics: Genomic data management platform enabling scalable, secure analysis for precision medicine. ● HyperCare: All-in-one in-hospital communication and workforce management platform.

2020 - 2023

  • Senior Associate

    2023 - 2023

    ● Stakeholder engagement: Worked closely with partners as one of the first employees of the firm to grow from a first fund of $20M to a second fund of $45M with more than 35 investments across North America, Europe and Israel. ● Team lead: Managed, trained and led a team of analysts while coordinating with the partners of the firm to ensure successful closing of investment opportunities within established deadlines. ● Portfolio management: Provided guidance and oversight as an active board member for portfolio companies on key business decisions such as fundraising efforts, executive hiring, go-to-market strategies, regulatory pathway, reimbursement, geographic prioritization, and growth scaling.

  • Associate

    2021 - 2023

    ● Investment Due Diligence: Led the investment process from initial screening to closing, including due diligence, presentation to the investment committee, negotiation of terms with founders, and drafting of investment documents.

  • Investment Analyst

    2020 - 2021

    ● Dealflow: Successfully sourced several opportunities that resulted in investments and successful exits (+5x multiples on initial investment). ● Investment Screening & Due Diligence: Screened investment opportunities in the European market and conducted corresponding due diligence.

  • Business Analyst

    2019 - 2019

    ● Modeling: Validated commercial credit models to ensure compliance with banking regulations (Basel Framework). ● Data Analysis: Developed statistical models and performed data analysis using SQL, Python, and VBA to extract actionable insights from large datasets.